Overview
Ulrike Lischetti practices practicing medicine in Basel, Switzerland.
Her clinical expertise encompasses Melanoma, Ovarian Cancer, and Immune Defect due to Absence of Thymus.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Basel, BS, Switzerland
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ulrike Lischetti
Is Ulrike Lischetti a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Ulrike Lischetti is classified as an Experienced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ulrike Lischetti participate in research or clinical trials?
Yes. Ulrike Lischetti has published 9 articles and abstracts on conditions like Melanoma. You can view a list of Ulrike Lischetti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Immune Defect due to Absence of ThymusMs. Lischetti isExperienced. Learn about Immune Defect due to Absence of Thymus.
- MelanomaMs. Lischetti isExperienced. Learn about Melanoma.
- Ovarian CancerMs. Lischetti isExperienced. Learn about Ovarian Cancer.